Literature DB >> 10593858

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

E Piek1, C H Heldin, P Ten Dijke.   

Abstract

Transforming growth factor-beta (TGF-beta) superfamily members are multifunctional cell-cell signaling proteins that play pivotal roles in tissue homeostasis and development of multicellular animals. They mediate their pleiotropic effects from membrane to nucleus through distinct combinations of type I and type II serine/threonine kinase receptors and their downstream effectors, known as Smad proteins. Certain Smads, termed receptor-regulated Smads, become phosphorylated by activated type I receptors and form heteromeric complexes with a common-partner Smad4, which translocates into the nucleus to control gene transcription. In addition to these signal transducing Smads, inhibitory Smads have been identified that inhibit the activation of receptor-regulated Smads. In contrast to the still growing TGF-beta superfamily (with approximately 30 members in mammals), relatively few type I and type II receptors as well as Smads have been identified. We will focus on recent insights into the molecular mechanisms by which signaling specificity between different TGF-beta superfamily members is achieved and regulated, and how a single family member can elicit a broad scala of biological responses.-Piek, E., Heldin, C.-H., ten Dijke, P. Specificity, diversity, and regulation in TGF-beta superfamily signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593858

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  156 in total

1.  Transforming growth factor beta contributes to progressive diabetic nephropathy.

Authors:  W B Reeves; T E Andreoli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.

Authors:  Takashi Kanamoto; Ulf Hellman; Carl-Henrik Heldin; Serhiy Souchelnytskyi
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

3.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Authors:  Ester Piek; Maarten Van Dinther; W Tony Parks; John M Sallee; Erwin P Böttinger; Anita B Roberts; Peter Ten Dijke
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 6.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

7.  Smad1 and Smad5 differentially regulate embryonic hematopoiesis.

Authors:  Lisa J McReynolds; Sunny Gupta; Maria E Figueroa; Mary C Mullins; Todd Evans
Journal:  Blood       Date:  2007-08-29       Impact factor: 22.113

8.  Marfan syndrome and mitral valve prolapse.

Authors:  Arthur E Weyman; Marielle Scherrer-Crosbie
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  Transforming growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell differentiation through TGFRII-CK1ε-β-catenin signalling.

Authors:  Wang Qiong; Gu Xiaofeng; Wang Junfang
Journal:  Int J Exp Pathol       Date:  2018-08-02       Impact factor: 1.925

10.  Disruption of bidirectional oocyte-cumulus paracrine signaling during in vitro maturation reduces subsequent mouse oocyte developmental competence.

Authors:  Christine X Yeo; Robert B Gilchrist; Michelle Lane
Journal:  Biol Reprod       Date:  2009-01-14       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.